• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CHM 8.82% 3.1¢

CHIMERIC THERAPEUTICS LIMITED

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CHM
Charting Only
6 7 8
08:43 422 144K
08:43 Last post  dalts66 Comments Created with Sketch.  422  Views Created with Sketch.  144K 
CHM
Chimeric: Media Thread
10 11 12
19/04/24 668 266K
19/04/24 Last post  pinch2020 Comments Created with Sketch.  668  Views Created with Sketch.  266K 
CHM 09/04/24 2 1.0K
09/04/24 Last post  KrushingIt Comments Created with Sketch.  2  Views Created with Sketch.  1.0K 
CHM 08/04/24 0 275
08/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  275 
CHM 08/04/24 14 4.5K
08/04/24 Last post  Werble Comments Created with Sketch.  14  Views Created with Sketch.  4.5K 
CHM 02/04/24 1 650
02/04/24 Last post  FredQuell Comments Created with Sketch.  1  Views Created with Sketch.  650 
CHM 02/04/24 40 16K
02/04/24 Last post  pinch2020 Comments Created with Sketch.  40  Views Created with Sketch.  16K 
CHM 28/03/24 0 329
28/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  329 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice PH
08 Apr 17:03
 
Change of Director's Interest Notice PH
08 Apr 17:00
 
US patent allowed for CHM 0201 (CORE-NK) technology
05 Apr 08:50
 
Notification of cessation of securities - CHM
02 Apr 16:58
 
Notice under section 708A
28 Mar 16:56
 
Application for quotation of securities - CHM
28 Mar 16:51
 
View More arrow Created with Sketch.
(20min delay)
Last
3.1¢
Change
-0.003(8.82%)
Mkt cap ! $26.40M
Open High Low Value Volume
3.4¢ 3.4¢ 2.9¢ $222.5K 7.171M

Buyers (Bids)

No. Vol. Price($)
1 5 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 125000 1
View Market Depth
Last trade - 16.10pm 19/04/2024 (20 minute delay) ?
Last
3.1¢
  Change
-0.003 ( 11.4 %)
Open High Low Volume
3.4¢ 3.4¢ 2.9¢ 4181329
Last updated 15.30pm 19/04/2024 ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.